Clinical

Dataset Information

0

Phase III Study of Trifluridine/Tipiracil in Combination With Bevacizumab vs Trifluridine/Tipiracil Single Agent in Patients With Refractory Metastatic Colorectal Cancer


ABSTRACT: This study is designed as an international, open-label, controlled two-arm, randomized phase III comparison study evaluating the efficacy and safety of trifluridine/tipiracil in combination with bevacizumab versus trifluridine/tipiracil monotherapy in patients with refractory mCRC.

DISEASE(S): Refractory Metastatic Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2366035 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2403437 | ecrin-mdr-crc
| 60837 | ecrin-mdr-crc
| 2386782 | ecrin-mdr-crc
| S-EPMC8658167 | biostudies-literature
2017-09-25 | GSE96786 | GEO
2017-09-25 | GSE96785 | GEO
| 2307445 | ecrin-mdr-crc
| 2383608 | ecrin-mdr-crc
| 2401722 | ecrin-mdr-crc
| 2392221 | ecrin-mdr-crc